Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
XG014 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/12/2021 1 0
WNbFc 7 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021 1 0
WNbFc 36 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021 1 0
WNbFc 2 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021 1 0
WNbFc 15 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021 1 0
W25 Potential treatment - pre-clinical evidence Experimental Antiviral Feb/08/2021 1 0
VHH WE Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021 1 0
VHH W Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021 1 0
VHH VE Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021 1 0
VHH V Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021 1 0